glp-1 drugs moa glp-1_analogs [TUSOM List of GLP-1 Receptor Agonists

On a medication that already slows gastric emptying, adding a fiber that expands dramatically in the stomach can cause significant discomfort, nausea, or even exacerbate bloating symptoms

Save cancellation confirmation and verify that medication refills are also stopped

however, trials are investigating the agent in type 2 diabetes and obesity

The FDA's 2025-2026 labeling update reinforces this picture

Schenker, N

The development of these agents underscores the continuous improvement of the pharmacokinetic and pharmacodynamic profiles of these peptide agents [ Table 1 ], expanding their applications beyond T2DM and obesity to encompass cardiovascular disease event reduction [ Table 2 ]